Viewing Study NCT03660761


Ignite Creation Date: 2025-12-24 @ 12:06 PM
Ignite Modification Date: 2026-02-21 @ 11:18 PM
Study NCT ID: NCT03660761
Status: COMPLETED
Last Update Posted: 2019-04-16
First Post: 2018-08-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors
Sponsor: Rongjie Tao
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module